Proliferation index has garnered substantial attention as a prognostic indicator in breast cancer, as molecular subtyping of human breast cancers using Ki67 can differentiate good prognostic luminal A from poor prognostic luminal B subtypes.48 Our quantification of tumor Ki67 labeling revealed an increase in luminal B diagnoses in young women’s breast cancers. This evidence concerns the gene MKI67 and neoplasm.